Market cap
$4.8bn
Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.
Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.
During the second quarter of fiscal 2027, we repaid an additional $50.0 million on the revolving credit facility. Financial Summary Net revenues increased 5.6% during the three months ended June 27, 2026 as compared with the same period of fiscal 2026. This was primarily attributable to revenue increases in Apheresis, driven by volume growth and share gains within the Plasma franchise, and revenue increases in MedSurg, driven by share gains in the Hemostasis Management and Transfusion Management product lines within the Blood Management Technologies franchise. Operating income increased 6.7% during the three months ended June 27, 2026 as compared with the same period of fiscal 2026. …HAEMONETICS CORP, 10-Q, period ended 2026-06-27, filed 2026-08-06